Press-release for stocks publishing date 2022 - 11

Prices are updated after-hours

publishing date : 2022 - 11 - 10 tags : Therapeutics

save search

Iterum Therapeutics Reports Third Quarter 2022 Financial Results
Published: 2022-11-10 (Crawled : 14:20) - globenewswire.com
ITRM | $1.42 -2.07% -2.11% 75K

Health Technology

| 1.75% | O: -2.46% H: 7.19% C: 2.88%
therapeutics financial results

Nabriva Therapeutics Pivoting Strategic Focus Reports Third Quarter Financial Results and Provides Corporate Update
Published: 2022-11-10 (Crawled : 14:20) - globenewswire.com
NBRV | $1.42 1.39% 720K

Health Technology

| -34.87% | O: 0.91% H: 7.27% C: 5.0%
update therapeutics financial results

Aclaris Therapeutics to Participate in Two November Healthcare Investor Conferences
Published: 2022-11-10 (Crawled : 05:00) - globenewswire.com
ACRS | $1.23 0.82% 0.81% 560K

Health Technology

| -92.8% | O: 0.12% H: 1.71% C: 0.12%
therapeutics

Astria Therapeutics Reports Third Quarter 2022 Financial Results and Provides a Corporate Update
Published: 2022-11-10 (Crawled : 00:00) - biospace.com/
ATXS | $10.53 -5.14% -5.41% 550K

Manufacturing

| 46.63% | O: 3.04% H: 1.41% C: -4.62%
therapeutics financial update results

Lineage Cell Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
Published: 2022-11-10 (Crawled : 00:00) - biospace.com/
LCTX | $1.29 12.17% 0.0% 2.3M

Health Technology

| -8.0% | O: 1.6% H: 6.3% C: 4.72%
therapeutics financial update results

Avenue Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
Published: 2022-11-10 (Crawled : 00:00) - biospace.com/
AZNCF | $135.305 -4.19% 1.1K

Health Technology

| 12.29% | O: 6.22% H: 3.13% C: -0.56%
FBIO | $1.79 1.7% 1.68% 240K

Health Technology

| 128.96% | O: 0.17% H: 6.48% C: -1.81%
ATXI | $0.1361 3.5% 3.38% 800K

Health Technology

| -93.01% | O: -10.64% H: 30.29% C: 25.6%
AZN | $68.53 0.39% 0.39% 3.7M

Health Technology

| 11.82% | O: 7.08% H: 0.84% C: -0.43%
therapeutics financial results

AgeX Therapeutics Reports Third Quarter 2022 Financial Results
Published: 2022-11-10 (Crawled : 00:00) - biospace.com/
AGE A | $11.1 0.0% 3.8K

Health Technology

| 1620.13% | O: -4.88% H: 1.01% C: -6.48%
therapeutics financial results

Poseida Therapeutics Provides Updates and Financial Results for the Third Quarter of 2022
Published: 2022-11-10 (Crawled : 00:00) - biospace.com/
PSTX | News | $2.03 0.0% 980K

Health Technology

| -52.9% | O: 4.18% H: 3.56% C: 0.22%
therapeutics financial

Regulus Therapeutics Reports Third Quarter 2022 Financial Results and Recent Updates
Published: 2022-11-10 (Crawled : 00:00) - biospace.com/
RGLS | $2.345 -8.4% -9.17% 290K

Health Technology

| 55.15% | O: -1.21% H: 3.07% C: -0.31%
therapeutics financial results

Relmada Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results
Published: 2022-11-10 (Crawled : 00:00) - biospace.com/
RLMD | $4.67 2.41% 2.36% 85K

Health Technology

| -20.83% | O: 3.82% H: 0.84% C: -2.34%
therapeutics financial update results

vTv Therapeutics Announces 2022 Third Quarter Financial Results and Provides Corporate Update
Published: 2022-11-10 (Crawled : 23:00) - globenewswire.com
VTVT | $24.08 -0.21% -0.21% 16K

Health Technology

| 2522.54% | O: 4.34% H: 0.0% C: -6.46%
therapeutics financial update results

CRISPR Therapeutics Presents Data at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
Published: 2022-11-10 (Crawled : 23:00) - globenewswire.com
CRSP M | $55.56 -4.14% -4.32% 1.4M

Health Technology

| 5.98% | O: -1.01% H: 14.93% C: 11.47%
crispr immunotherapy meeting therapeutics cancer

VYNE Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
Published: 2022-11-10 (Crawled : 22:00) - vynetherapeutics.com
VYNE | $2.41 -0.41% -0.41% 31K

Health Technology

| -45.41% | O: 8.28% H: 0.0% C: -6.26%
therapeutics financial update results

Akero Therapeutics to Present at Upcoming Healthcare Conferences in November
Published: 2022-11-10 (Crawled : 22:00) - ir.akerotx.com
AKRO | $21.62 -0.78% -0.79% 820K

Health Technology

| -44.82% | O: 0.35% H: 5.4% C: 2.55%
therapeutics